• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管通透性因子/血管内皮生长因子介导的小鼠肠系膜血管内皮细胞信号传导

Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.

作者信息

Mukhopadhyay D, Nagy J A, Manseau E J, Dvorak H F

机构信息

Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA.

出版信息

Cancer Res. 1998 Mar 15;58(6):1278-84.

PMID:9515816
Abstract

Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) is a multifunctional cytokine and growth factor that has important roles in both pathological and physiological angiogenesis. VPF/VEGF induces vascular hyperpermeability, cell division, and other activities by interacting with two specific receptor tyrosine kinases, KDR/Flk-1 and Flt-1, that are selectively expressed on vascular endothelium. The signaling cascade that follows VPF/VEGF interaction with cultured endothelium is only partially understood but is known to result in increased intracellular calcium, activation of protein kinase C, and tyrosine phosphorylations of both receptors, phospholipase C-gamma (PLC-gamma) and phosphatidylinositol 3'-kinase. For many reasons, signaling events elicited in cultured endothelium may not mimic mediator effects on intact normal or tumor-induced microvessels in vivo. Therefore, we developed a system that would allow measurement of VPF/VEGF-induced signaling on intact microvessels. We used mouse mesentery, a tissue whose numerous microvessels are highly responsive to VPF/VEGF and that we found to express Flk-1 and Flt-1 selectively. At intervals after injecting VPF/VEGF i.p., mesenteries were harvested, extracted, and immunoprecipitated. Immunoblots confirmed that VPF/VEGF induced tyrosine phosphorylation of several proteins in mesenteric microvessels as in cultured endothelium: Flk-1; PLC-gamma; and mitogen-activated protein kinase. Similar phosphorylations were observed when mesentery was exposed to VPF/VEGF in vitro, or when mesenteries were harvested from mice bearing the mouse ovarian tumor ascites tumor, which itself secretes abundant VPF/VEGF. Other experiments further elucidated the VPF/VEGF signaling pathway, demonstrating phosphorylation of both PYK2 and focal adhesion kinase, activation of c-jun-NH2-kinase with phosphorylation of c-Jun, and an association between Flk-1 and PLC-gamma. In addition, we demonstrated translocation of mitogen-activated protein kinase to the cell nucleus in cultured endothelium. Taken together, these experiments describe a new model system with the potential for investigating signaling events in response to diverse mediators on intact microvessels in vivo and have further elucidated the VPF/VEGF signaling cascade.

摘要

血管通透因子/血管内皮生长因子(VPF/VEGF)是一种多功能细胞因子和生长因子,在病理性和生理性血管生成中均发挥重要作用。VPF/VEGF通过与两种特异性受体酪氨酸激酶KDR/Flk-1和Flt-1相互作用,诱导血管高通透性、细胞分裂及其他活动,这两种受体酪氨酸激酶在血管内皮上选择性表达。VPF/VEGF与培养的内皮细胞相互作用后引发的信号级联反应仅部分为人所知,但已知会导致细胞内钙增加、蛋白激酶C激活以及两种受体、磷脂酶C-γ(PLC-γ)和磷脂酰肌醇3'-激酶的酪氨酸磷酸化。由于多种原因,培养的内皮细胞中引发的信号事件可能无法模拟介质对体内完整正常或肿瘤诱导的微血管的作用。因此,我们开发了一种系统,可用于测量VPF/VEGF对完整微血管诱导的信号传导。我们使用小鼠肠系膜,该组织中的众多微血管对VPF/VEGF高度敏感,且我们发现其选择性表达Flk-1和Flt-1。腹腔注射VPF/VEGF后每隔一定时间,采集肠系膜,进行提取和免疫沉淀。免疫印迹证实,VPF/VEGF如在培养的内皮细胞中一样,诱导肠系膜微血管中几种蛋白质的酪氨酸磷酸化:Flk-1、PLC-γ和丝裂原活化蛋白激酶。当肠系膜在体外暴露于VPF/VEGF时,或从携带小鼠卵巢肿瘤腹水瘤(其自身分泌大量VPF/VEGF)的小鼠中采集肠系膜时,观察到类似的磷酸化。其他实验进一步阐明了VPF/VEGF信号通路,证明了PYK2和粘着斑激酶均发生磷酸化,c-Jun氨基末端激酶因c-Jun磷酸化而激活,以及Flk-1与PLC-γ之间存在关联。此外,我们证明了丝裂原活化蛋白激酶在培养的内皮细胞中易位至细胞核。综上所述,这些实验描述了一种新的模型系统,有潜力研究体内完整微血管对多种介质产生反应时的信号事件,并进一步阐明了VPF/VEGF信号级联反应。

相似文献

1
Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.血管通透性因子/血管内皮生长因子介导的小鼠肠系膜血管内皮细胞信号传导
Cancer Res. 1998 Mar 15;58(6):1278-84.
2
A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.一种源自FLT酪氨酸激酶(血管内皮生长因子VEGF的受体)的独特信号转导。
Oncogene. 1995 Jan 5;10(1):135-47.
3
The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts.KDR/Flk-1(血管内皮生长因子受体-2)的230 kDa成熟形式激活PLC-γ途径,并在NIH3T3成纤维细胞中部分诱导有丝分裂信号。
Oncogene. 1997 May 1;14(17):2079-89. doi: 10.1038/sj.onc.1201047.
4
Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.通过抑制血管内皮生长因子受体酪氨酸激酶磷酸化治疗人肺腺癌恶性胸腔积液
Clin Cancer Res. 2000 Mar;6(3):957-65.
5
Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.白细胞介素-1β通过激活蛋白酪氨酸激酶上调血管内皮生长因子及其受体KDR/flk-1在心脏中的表达。
J Mol Cell Cardiol. 1999 Mar;31(3):607-17. doi: 10.1006/jmcc.1998.0895.
6
Autophosphorylation of KDR in the kinase domain is required for maximal VEGF-stimulated kinase activity and receptor internalization.激酶结构域中KDR的自磷酸化是最大程度的VEGF刺激激酶活性和受体内化所必需的。
Oncogene. 1999 Feb 25;18(8):1619-27. doi: 10.1038/sj.onc.1202478.
7
Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor.子宫平滑肌细胞表达血管通透性因子/血管内皮生长因子的功能性受体(flt-1和KDR)。
Lab Invest. 1997 Feb;76(2):245-55.
8
A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells.KDR/Flk-1 上的单个自磷酸化位点对于血管内皮细胞中 VEGF-A 依赖的 PLC-γ 激活和 DNA 合成至关重要。
EMBO J. 2001 Jun 1;20(11):2768-78. doi: 10.1093/emboj/20.11.2768.
9
VEGF-induced activation of phosphoinositide 3-kinase is dependent on focal adhesion kinase.血管内皮生长因子诱导的磷酸肌醇3激酶激活依赖于粘着斑激酶。
Exp Cell Res. 2001 Feb 1;263(1):173-82. doi: 10.1006/excr.2000.5102.
10
The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor.神经递质多巴胺可抑制血管通透性因子/血管内皮生长因子诱导的血管生成。
Nat Med. 2001 May;7(5):569-74. doi: 10.1038/87895.

引用本文的文献

1
Effect of Dietary Supplements with ω-3 Fatty Acids, Ascorbic Acid, and Polyphenolic Antioxidant Flavonoid on Gene Expression, Organ Failure, and Mortality in Endotoxemia-Induced Septic Rats.含ω-3脂肪酸、抗坏血酸和多酚抗氧化剂类黄酮的膳食补充剂对内毒素血症诱导的脓毒症大鼠基因表达、器官衰竭及死亡率的影响
Antioxidants (Basel). 2023 Mar 7;12(3):659. doi: 10.3390/antiox12030659.
2
Molecular identification of protein kinase C beta in Alzheimer's disease.阿尔茨海默病中蛋白激酶 Cβ的分子鉴定。
Aging (Albany NY). 2020 Nov 7;12(21):21798-21808. doi: 10.18632/aging.103994.
3
Afatinib, an EGFR inhibitor, decreases EMT and tumorigenesis of Huh‑7 cells by regulating the ERK‑VEGF/MMP9 signaling pathway.
阿法替尼,一种表皮生长因子受体抑制剂,通过调节 ERK-VEGF/MMP9 信号通路降低 Huh-7 细胞的 EMT 和致瘤性。
Mol Med Rep. 2019 Oct;20(4):3317-3325. doi: 10.3892/mmr.2019.10562. Epub 2019 Aug 6.
4
Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation.肿瘤代谢物琥珀酸通过GPR91介导的STAT3和ERK激活上调VEGF表达,从而促进血管生成。
Oncotarget. 2017 Feb 21;8(8):13174-13185. doi: 10.18632/oncotarget.14485.
5
Metronomic chemotherapy and anti-angiogenesis: can upgraded pre-clinical assays improve clinical trials aimed at controlling tumor growth?节拍化疗与抗血管生成:升级的临床前检测能否改善旨在控制肿瘤生长的临床试验?
APMIS. 2014 Jul;122(7):565-79. doi: 10.1111/apm.12201. Epub 2013 Oct 26.
6
Angiogenesis-related pathways in the pathogenesis of ovarian cancer.卵巢癌发病机制中的血管生成相关途径。
Int J Mol Sci. 2013 Jul 30;14(8):15885-909. doi: 10.3390/ijms140815885.
7
Adhesion of malignant mammary tumor cells MDA-MB-231 to microvessel wall increases microvascular permeability via degradation of endothelial surface glycocalyx.恶性乳腺肿瘤细胞 MDA-MB-231 黏附于微血管壁会通过降解内皮表面糖萼增加微血管通透性。
J Appl Physiol (1985). 2012 Oct;113(7):1141-53. doi: 10.1152/japplphysiol.00479.2012. Epub 2012 Aug 2.
8
Microvascular transport and tumor cell adhesion in the microcirculation.微血管内的转运和肿瘤细胞黏附。
Ann Biomed Eng. 2012 Nov;40(11):2442-55. doi: 10.1007/s10439-012-0561-0. Epub 2012 Apr 3.
9
Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated angiogenesis.低剂量节拍化疗与血管生成:拓扑异构酶抑制剂伊立替康和米托蒽醌刺激 VEGF-A 介导的血管生成。
APMIS. 2012 Feb;120(2):147-56. doi: 10.1111/j.1600-0463.2011.02830.x. Epub 2011 Oct 25.
10
Vascular endothelial growth factor enhances cancer cell adhesion to microvascular endothelium in vivo.血管内皮生长因子增强体内癌细胞与微血管内皮的黏附。
Exp Physiol. 2010 Feb;95(2):369-79. doi: 10.1113/expphysiol.2009.050260. Epub 2009 Oct 30.